🌐 NEWS: Curebase raises its $15M Series A led by GGV Capital. Read about it in Crunchbase, FierceBiotech, and MedCity News.
Curebase Founder and CEO, Tom Lemberg, shares what inspired him to quite literally, build Curebase, from the ground up and reflects on his unique background as a software engineer turned CEO.
Jane Myles, VP of Clinical Trial Innovation at Curebase, highlights how decentralizing clinical trials can improve access to medical care and equity in men's health.
Curebase is increasing diversity in clinical research by engaging more patients in real-world data collection
Our new Director of Clinical Operations, Adam Samson, discusses the future of decentralized clinical trials and his vision for Curebase.
At Curebase, we are making decentralized clinical trials a reality. And, that means establishing new, innovative methods to collect high-quality data.
At Curebase we are rapidly expanding and preparing for the wave of decentralization in clinical trials that we intend to lead. To that end we have recently hired a Director of Clinical Operations, Adam Samson...
At Curebase we are rapidly expanding and preparing for the wave of decentralization in clinical trials that we intend to lead. To that end we have recently hired a Director of Clinical Operations, Adam Samson...
